These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12815953)

  • 1. [The protective role of p53 in Ras-induced transformation of REF52 cells].
    Kopnin PB; Ivanov AV; Il'inskaia GV; Sablina AA; Kopnin BP; Chumakov PM
    Mol Biol (Mosk); 2003; 37(3):458-71. PubMed ID: 12815953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53-dependent effects of RAS oncogene on chromosome stability and cell cycle checkpoints.
    Agapova LS; Ivanov AV; Sablina AA; Kopnin PB; Sokova OI; Chumakov PM; Kopnin BP
    Oncogene; 1999 May; 18(20):3135-42. PubMed ID: 10340385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in p53 expression can modify cell shape of ras-transformed fibroblasts and epitheliocytes.
    Gloushankova N; Ossovskaya V; Vasiliev J; Chumakov P; Kopnin B
    Oncogene; 1997 Dec; 15(24):2985-9. PubMed ID: 9416842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rat embryo fibroblasts transformed by complementation with oncogenes E1A+E1B-19 and E1A+cHa-ras differ in the ability to realize the G1/S block in serum free media].
    Brichkina AI; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
    Tsitologiia; 2001; 43(11):1024-30. PubMed ID: 11840777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of p53/p21waf1 pathway is associated with senescence during v-Ha-ras transformation of immortal C2C12 myoblasts.
    D'Orazi G; Soddu S; Sacchi A
    Anticancer Res; 2000; 20(5B):3497-502. PubMed ID: 11131653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immortalization of rat embryo fibroblasts by the cellular p53 oncogene.
    Rovinski B; Benchimol S
    Oncogene; 1988 May; 2(5):445-52. PubMed ID: 3287278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling of fibroblasts resistant toward oncogene-mediated transformation reveals preferential transcription of negative growth regulators.
    Tchernitsa OI; Zuber J; Sers C; Brinckmann R; Britsch SK; Adams V; Schäfer R
    Oncogene; 1999 Sep; 18(39):5448-54. PubMed ID: 10498898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line.
    Zongaro S; de Stanchina E; Colombo T; D'Incalci M; Giulotto E; Mondello C
    Cancer Res; 2005 Dec; 65(24):11411-8. PubMed ID: 16357149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RhoE inhibits cell cycle progression and Ras-induced transformation.
    Villalonga P; Guasch RM; Riento K; Ridley AJ
    Mol Cell Biol; 2004 Sep; 24(18):7829-40. PubMed ID: 15340047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
    Woo RA; Poon RY
    Genes Dev; 2004 Jun; 18(11):1317-30. PubMed ID: 15175263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1.
    Chen C; Chang YC; Liu CL; Chang KJ; Guo IC
    Breast Cancer Res Treat; 2006 Jul; 98(2):121-32. PubMed ID: 16752079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular senescence induced by p53-ras cooperation is independent of p21waf1 in murine embryo fibroblasts.
    Castro ME; del Valle Guijarro M; Moneo V; Carnero A
    J Cell Biochem; 2004 Jun; 92(3):514-24. PubMed ID: 15156563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
    Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS
    Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-ras oncogene-induced gene expression in human hematopoietic progenitor cells: upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation.
    Shen S; Passioura T; Symonds G; Dolnikov A
    Exp Hematol; 2007 Jun; 35(6):908-19. PubMed ID: 17533045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a second cell cycle block at G2/M by p53.
    Stewart N; Hicks GG; Paraskevas F; Mowat M
    Oncogene; 1995 Jan; 10(1):109-15. PubMed ID: 7529916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 mutations and tetraploids under r- and K-selection.
    Chikatsu N; Nakamura Y; Sato H; Fujita T; Asano S; Motokura T
    Oncogene; 2002 May; 21(19):3043-9. PubMed ID: 12082535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anchorage-independent growth of pocket protein-deficient murine fibroblasts requires bypass of G2 arrest and can be accomplished by expression of TBX2.
    Vormer TL; Foijer F; Wielders CL; te Riele H
    Mol Cell Biol; 2008 Dec; 28(24):7263-73. PubMed ID: 18936168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse p10, an alternative spliced form of p15INK4b, inhibits cell cycle progression and malignant transformation.
    Pérez de Castro I; Benet M; Jiménez M; Alzabin S; Malumbres M; Pellicer A
    Cancer Res; 2005 Apr; 65(8):3249-56. PubMed ID: 15833857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indistinct cell cycle checkpoint after u.v. damage in H-ras-transformed mouse liver cells despite normal p53 gene expression.
    Kadohama T; Tsuji K; Ogawa K
    Oncogene; 1994 Oct; 9(10):2845-52. PubMed ID: 8084590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.